Bruce Ovbiagele M.D., MSCR

Bruce I. Ovbiagele M.D., MSCR
Provider Image
  • Professor
  • Chair, Department of Neurology
  • Admiral Paul E. Pihl Endowed Chair of Neurosciences
Degree M.D., MSCR
School University of Lagos; University of California San Diego
  • University of California, Irvine
  • University of California, Los Angeles
Board Certification
  • Neurology
  • Neurology: Vascular Neurology
  • Neurology - Stroke Neurology
  • Neurology
Accepts New Patients No


Rutledge Tower
135 Rutledge Avenue
Charleston, SC 29425
Map & Directions


Bruce Ovbiagele, M.D., MSc, MAS is Professor and Chairman of the Department Neurology at the Medical University of South Carolina (SC, USA). He is an elected Fellow of the Royal College of Physicians (London), American Academy of Neurology, American Neurological Association, American Heart Association Stroke Council, and European Stroke Organization. Dr. Ovbiagele also serves on the faculty of Capital Medical University in Beijing, China and Favaloro University in Buenos Aires, Argentina.  

Dr. Ovbiagele is the current Chair of the International Stroke Conference, the premier scientific stroke conference in the world. He is an Officer of the World Federation of Neurology, as well as serving as a member of the National Institute of Neurological Disorders Advisory Council and the FDA Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee. Dr. Ovbiagele serves on the editorial boards of several stroke journals; has published over 330 peer-reviewed papers on stroke epidemiology, stroke prevention, and T2/T3 translational stroke research; edited 3 textbooks; and mentored numerous students, residents and fellows, and early career faculty.  He is an active researcher with current funding from the National Institutes of Health (NIH). Ongoing NIH research grants include a study exploring the genomic and phenomic aspects of stroke in Sub-Saharan Africa, a randomized controlled trial of multipronged practice intervention to improve blood pressure control among stroke survivors, and an mhealth-based/task-shifting strategy to treat hypertension.